Ogivri Interactions
There are 177 drugs known to interact with Ogivri (trastuzumab), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 52 are major, and 125 are moderate.
- View all 177 medications that may interact with Ogivri
- View Ogivri alcohol/food interactions (1)
- View Ogivri disease interactions (4)
Most frequently checked interactions
View interaction reports for Ogivri (trastuzumab) and the medicines listed below.
- Adriamycin (doxorubicin)
- Alphanate (antihemophilic factor/von willebrand factor)
- Amicar (aminocaproic acid)
- apalutamide
- Aristada (aripiprazole)
- atoltivimab / maftivimab / odesivimab
- BabyBIG (botulism immune globulin)
- Banzel (rufinamide)
- baricitinib
- BayGam (immune globulin intramuscular)
- Biaxin XL (clarithromycin)
- bleomycin
- Brevital Sodium (methohexital)
- Cafergot (caffeine / ergotamine)
- ceftriaxone
- chloramphenicol
- Cipro XR (ciprofloxacin)
- clarithromycin
- clofazimine
- clonidine
- Erelzi (etanercept)
- hydroxychloroquine
- Jantoven (warfarin)
- Kyprolis (carfilzomib)
- Proleukin (aldesleukin)
- Propulsid (cisapride)
- remdesivir
- Rifater (isoniazid / pyrazinamide / rifampin)
- ritonavir
- Xigris (drotrecogin alfa)
Ogivri alcohol/food interactions
There is 1 alcohol/food interaction with Ogivri (trastuzumab).
Ogivri disease interactions
There are 4 disease interactions with Ogivri (trastuzumab) which include:
More about Ogivri (trastuzumab)
- Ogivri consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: HER2 inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.